Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Retrophin sells pediatric disease priority review voucher to Sanofi for $245mm

Executive Summary

Retrophin Inc. sold its rare pediatric disease priority review voucher (PRV) to Sanofi for $245mm. Sanofi paid $150mm up front, and will make two equal payments of $47.5mm in 2016 and 2017.
Deal Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
Deal Status
  • Final
Deal Type
  • Financing
    • Other

Related Companies

UsernamePublicRestriction

Register